Table 2

Multivariable logistic regression analysis of effect of higher oxygen saturation targets on ROP outcomes, controlling for other possible confounding predictors

Outcome
intercept
Any ROP
(n=188/627)
ROP that progressed
(n=49/188)
ROP requiring treatment
(n=63/188)
IVH
(n=201/622)
P valueOR
(95% CI)
P valueOR
(95% CI)
P valueOR (95% CI)P valueOR (95% CI)
Higher oxygen
(epoch 2)
(n=344/651)
0.00122.2 (1.36 to 3.44)0.0093.0 (1.31 to 6.81)0.220.65 (0.32 to 1.29)<0.00016.75 (4.13 to 11.03)
Sepsis present
(n=368/620)
0.00052.5 (1.48 to 4.2)0.380.64 (0.24 to 1.70)0.052.62 (0.9 to 6.9)0.231.36 (0.82 to 2.26)
Surfactant
(n=279/622)
0.380.79 (0.47 to 1.33)0.961.02 (0.38 to 2.72)0.720.88 (0.42 to 1.83)0.980.99 (0.59 to 1.66)
Steroid
(n=478/616)
0.781.07 (0.66 to 1.75)0.410.70 (0.29 to 1.65)0.581.24 (0.58 to 2.63)0.651.12 (0.69 to 1.79)
IPPV ≥7 days
(n=207/651)
<0.00015.01 (2.46 to 10.53)0.252.89 (0.47 to 7.71)0.00177.9* (2.17 to 28.82)0.00173.34 (1.57 to 7.08)
Transfusion
(n=317/623)
0.081.60 (0.95 to 2.70)0.0264.98* (1.22 to 20.39)0.421.47 (0.57 to 3.76)0.00642.09 (1.23 to 3.55)
Heart disease
(n=279/622)
0.0291.65 (1.05 to 2.57)0.920.95 (0.38 to 2.35)0.291.46 (0.71 to 2.97)0.0051.91 (0.82 to 2.26)
Birth weight
>1000 g
(n=417/626)
<0.00010.09 (0.05 to 0.16)NANA<0.00010.03 (0.01 to 0.07)NANA
Gestation
>28 weeks
(n=319/626)
<0.00010.08 (0.05 to 0.12)NANA<0.0010.09 (0.05 to 0.16)NANA
  • *This OR should be interpreted with caution since the 95% CI is too wide.

  • IPPV, invasive positive pressure ventilation; IVH, intraventricular haemorrhage; NA, not available/not analysed; ROP, retinopathy of prematurity.